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ABSTRACT: Bacterial pathogens containing type III protein
secretion systems (T3SS) assemble large needle-like protein
complexes in the bacterial envelope, called injectisomes, for
translocation of protein eﬀectors into host cells. The
application of these “molecular syringes” for the injection of
proteins into mammalian cells is hindered by their structural
and genomic complexity, requiring multiple polypeptides
encoded along with eﬀectors in various transcriptional units
(TUs) with intricate regulation. In this work, we have
rationally designed the controlled expression of the
ﬁlamentous injectisomes found in enteropathogenic Escherichia coli (EPEC) in the nonpathogenic strain E. coli K-12. All
structural components of EPEC injectisomes, encoded in a genomic island called the locus of enterocyte eﬀacement (LEE), were
engineered in ﬁve TUs (eLEEs) excluding eﬀectors, promoters and transcriptional regulators. These eLEEs were placed under
the control of the IPTG-inducible promoter Ptac and integrated into speciﬁc chromosomal sites of E. coli K-12 using a marker-
less strategy. The resulting strain, named synthetic injector E. coli (SIEC), assembles ﬁlamentous injectisomes similar to those in
EPEC. SIEC injectisomes form pores in the host plasma membrane and are able to translocate T3-substrate proteins (e.g.,
translocated intimin receptor, Tir) into the cytoplasm of HeLa cells reproducing the phenotypes of intimate attachment and
polymerization of actin-pedestals elicited by EPEC bacteria. Hence, SIEC strain allows the controlled expression of functional
ﬁlamentous injectisomes for eﬃcient translocation of proteins with T3S-signals into mammalian cells.
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Type III protein secretion systems (T3SS) are “molecularsyringes” found in many Gram-negative bacterial
pathogens specialized in the translocation of speciﬁc cytotoxic
proteins, called collectively as eﬀectors, into the cytoplasm of
host cells during infection.1,2 T3SSs assemble large multiring
protein complexes, referred to as injectisomes, comprising a
core cylindrical basal body that spans the bacterial inner
membrane (IM), the peptidoglycan (PG) and the outer
membrane (OM), and a hollow needle-like structure on the
extracellular surface of the bacterium.3 In some T3SS the
needle is extended by a long ﬁlament that allows plant
pathogens and some animal pathogens (e.g., enteropathogenic
Escherichia coli, EPEC) to access the plasma membrane of host
cells “at-a-distance”, translocating eﬀectors across the plant cell
wall or the mucus layer covering the apical surface of intestinal
epithelial cells.4,5 In the cytosolic entrance of the injectisomes, a
number of cytoplasmic and IM proteins, including a dedicated
ATPase, recognize eﬀectors bound to specialized T3SS
chaperones and energize dissociation of the chaperones and
secretion of eﬀectors through the needle complex.6−8 Some
injectisome proteins associated with the IM have structural and
sequence similarity with components of the ﬂagellar basal body,
indicating a common origin of both protein-export machi-
neries.2,9
Injectisomes have shown a great potential as nanomachines
for the delivery into eukaryotic cells of vaccine polypeptides
and proteins of therapeutic potential (e.g., transcription factors,
enzymes, antibody fragments) fused to short N-terminal
noncleavable signal sequences of eﬀectors.10−15 However, in
these studies the use of attenuated strains of T3SS-positive
pathogens was required for protein delivery. Engineered
expression of injectisomes in nonpathogenic bacteria has been
hindered by the intricate organization of diﬀerent genes and
operons needed for injectisome assembly16 and their complex
transcriptional regulation, which responds to various environ-
mental signals (e.g., temperature, pH, CO2, presence of divalent
ions, quorum sensing molecules).2 Moreover, the attenuated
strains of pathogens frequently express multiple eﬀectors that
are translocated into the host cell along with the protein of
interest. Hence, engineering nonpathogenic bacteria with a
controlled assembly of functional injectisomes would be
instrumental for the development of designed bacteria able to
deliver speciﬁc protein(s) into human cells for therapeutic
applications.
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EPEC and other related gastrointestinal pathogens, such as
enterohemorrhagic E. coli (EHEC) and Citrobacter rodentium,
carry a ﬁlamentous T3SS that allow these extracellular bacteria
to adhere to host enterocytes and subvert the barrier function
of the intestinal epithelium, causing a characteristic “attaching
and eﬀacing” (A/E) lesion.17,18 These pathogens translocate a
large set of eﬀector proteins (i.e., >25 eﬀectors in EPEC strain
E2348/69)19,20 that elicit multiple functions in the infected
cells, with strong rearrangement of the cytoskeleton, unbal-
anced cell proliferation and cell death in the epithelium, and
altered immune responses in the mucosa.17,21,22 The ﬁrst
eﬀector that is translocated by the T3SS of these pathogens is
the translocated intimin receptor (Tir), which inserts in the
plasma membrane of the enterocyte and exposes an
extracellular domain that is speciﬁcally recognized by the OM
protein intimin, causing an intimate adhesion of the
extracellular bacterium to the host cell plasma membrane.23,24
Once bound to intimin, Tir triggers actin polymerization in the
host cell cytoplasm, generating a characteristic pedestal-like
structure underneath the adhered bacterium.25
All proteins required for the assembly of the ﬁlamentous
T3SS of EPEC are encoded in a pathogenicity genomic island
of ∼35 kb called the locus of enterocyte eﬀacement (LEE)
(Figure 1A).26 The LEE includes 41 genes organized in ﬁve
major operons (LEE1, LEE2, LEE3, LEE4, LEE5) and other
transcriptional units (TUs) (grlRA, espG rorf1, etgA, cesF, map,
escD).27,28 All structural components of the injectisome are
encoded in the LEE (i.e., the cytosolic ATPase EscN, the basal
body proteins EscR, EscS, EscT, EscL, EscU, EscV, EscO, EscP,
and EscQ, the IM proteins EscD and EscJ, the inner rod
protein EscI, the OM secretin EscC, and the needle protein
EscF).2,9,29 The LEE also encodes the so-called “translocator”
Figure 1. Structure of LEE, of ﬁlamentous injectisomes of EPEC, and engineered operons. (A) Scheme of the LEE of EPEC, organized in ﬁve main
LEE operons (LEE1−LEE5) and other shorter transcriptional units. The functions of the LEE encoded proteins (e.g., injectisome structural protein,
translocator, eﬀector, chaperone, etc.) are indicated with the color code shown above the LEE. The DNA regions ampliﬁed in the engineered
operons (eLEE1, eLEE2, eLEE3, eLEE4, eEscD) are labeled at the bottom with a diﬀerent color for each operon. (B) Model showing the structure
of EPEC injectisomes comprising a basal body anchored to the bacterial envelope and an extracellular needle terminated with long extracellular
ﬁlament. The scheme indicates the proposed location of proteins that assemble the injectisome basal body (Esc proteins) in the bacterial inner and
outer membranes (IM and OM), the cytoplasmic ATPase (EscN), the components of the cytoplasmic switch complex (SepD, SepL, CesL), the
proteins building the extracellular needle (EscF) and ﬁlament (EspA), and those forming translocation pore in the host plasma membrane (EspB and
EspD). Cytoplasmic chaperones and the peptidoglycan (PG)-associated transglycosale (EtgA) are also indicated. Each protein is colored according
to its encoding operon (color code as in A). (C) Scheme showing the structure of the engineered operons integrated in the chromosome of E. coli K-
12. The Ptac promoter, transcriptional terminator, and ﬂanking homology regions (HRs) of the loci used for integration (yfaL, yeeJ, yra, yebT, yfc) are
indicated.
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proteins EspA, EspB and EspD, which are secreted through the
needle of a functional injectisome basal body. EspA polymerizes
a long extracellular hollow ﬁlament that extends the needle and
allows insertion of pore-forming proteins EspB and EspD in the
host plasma membrane.5,30−32
A model of EPEC injectisomes is shown in Figure 1B,
indicating the proposed location of the structural components
and identifying the TUs/operon encoding each subunit. The
LEE also encodes T3SS chaperones (CesT, CesF, CesAB,
CesA2, CesD, CesD2, EscE, EscG) that bind eﬀectors,
translocators and the needle protein in the cytoplasm prior to
their export through the injectisome. Finally, the LEE harbors
the genes encoding six eﬀectors (Tir, EspF, Map, EspH, EspG,
and EspZ),17 intimin (eae),24 a transglycosylase (EtgA),33 two
ORFs of unknown function (orf4, rorf1) and three transcrip-
tional regulators (Ler, GlrA, and GlrR).34,35 Transcription of
LEE operons and genes is highly regulated by external cues and
the physiological state of the bacterium.36,37 The ﬁrst gene
encoded in LEE1, ler, is the master transcriptional regulator
that activates the transcription of other LEE operons,
counteracting the inhibitory eﬀect of the global regulator H-
NS.34,38 High levels of Ler function as a repressor of LEE1,
creating a negative feedback loop.39 Other transciptional
regulators found in the LEE (e.g., GlrA/GlrR) and outside
the LEE (e.g., PerC) also control the expression of Ler.35,40
These regulatory genes also act outside the LEE. Ler activates
the autotransporter protease EspC41 whereas GlrA inhibits
transcription of the ﬂagellar master operon f lhCD under
conditions of T3SS expression.42 Under in vitro culture
conditions, expression of EPEC T3SS is induced when bacteria
are grown under conditions mimicking host environment (e.g.,
37 °C and 5% CO2 in DMEM). Lack of proper regulation may
explain the weak expression of the T3SS of EPEC in E. coli K-
12 harboring a cosmid with the entire LEE.26
In this work, we have engineered the controlled expression of
the ﬁlamentous injectisomes of EPEC in the nonpathogenic E.
coli K-12 strain MG1655 by constructing engineered LEE
operons encoding solely the components needed for the
assembly of functional injectisome and placed them under the
control of the heterologous inducible promoter Ptac. These
constructs were integrated into the chromosome of E. coli K-12
by a marker-less strategy, generating an engineered strain
named synthetic injector E. coli (SIEC), which upon induction
expresses injectisomes capable of eﬃcient protein translocation
into mammalian cells.
■ RESULTS AND DISCUSSION
Generation of the Synthetic Injector E. coli (SIEC)
Strain. Our aim was to integrate the genes needed for the
assembly of EPEC injectisomes in the chromosome of E. coli K-
12. We selected the genes encoding structural proteins (orf4,
escL, escR, escS, escT, escU, escC, escJ, escI, escV, escN, escO, escP,
escQ, escC and escF), the switch complex (sepD, sepL, cesL),
chaperones of injectisome components (escE, cesAB, cesD,
cesD2, escG), and the translocators (espA, espB, and espD)
(Figure 1A), and ruled out genes encoding eﬀectors (tir, map,
espF, espG, espZ, espH) and chaperones of eﬀectors (cesT, cesF),
intimin (eae), EtgA muramidase (etgA), and transcriptional
regulators (glrA, glrR, ler). The total genes selected summed up
27. We designed 5 TUs, referred to as operons eLEE1, eLEE2,
eLEE3, eLEE4 and eEscD (Figure 1A). The corresponding
DNA segments were ampliﬁed from the chromosome of EPEC
strain 2348/69,19 from the start codon of the ﬁrst selected gene
to the stop codon of the last one. The strategy implied the
exclusion of native promoters, terminators, and the ﬁrst
ribosome-binding site (RBS) found in the native LEE operons.
The parental strain for integration of eLEEs was E. coli K-12
MG1655 lacking type 1 ﬁmbriae operon Δf imA-H, named
Figure 2. SIEC bacteria express ﬁlamentous injectisomes upon induction. (A) Coomasie staining and Western blot of proteins in culture media of
the indicated strains (EPEC, EPECΔescN, SIEC, SIECΔp1, EcM1 and EcM1Δf liCD) induced (+) or not (−) with IPTG. Anti-EspA, -EspB and
-GroEL antibodies were used in Western blot. Detection of cytoplasmic GroEL was used to control for the absence of bacterial lysis. The protein
bands of T3SS translocators EspA, EspB, EspD, of autotransporter EspC, and ﬂagellin (FliC) are labeled on the right. Molecular weight markers are
indicated on the left (in kDa). (B) Western blot of the bacterial whole-cell protein extracts from the indicated bacterial strains, induced (+) or not
(−) with IPTG, detecting proteins of the T3SS (EscC, EscJ, EscD, EscN, EspB, EspA) and GroEL as a loading control. Identity of each protein band
is indicated on the right along with the encoding operon. (C) The proteins found in culture media of induced SIEC and EcM1/pCVD462 bacteria
(carrying cosmid with wt LEE) were analyzed by Coomasie staining and Western blot with anti-EspA and anti-EspB antibodies. The protein bands
of T3SS translocators EspA, EspB, EspD, and ﬂagellin (FliC) are labeled on the right.
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EcM1.43 For selection of the integration sites for eLEE operons,
we tested eight loci encoding adhesins of E. coli K-12 (yeeJ,
yebT, yra, yfaL, yfc, sfm, f lu, mat; Supporting Information Table
S1) because these are nonessential genes/operons whose
deletion would reduce the nonspeciﬁc adhesion of our
engineered bacteria.44−46 Gene expression in these sites was
analyzed integrating a reporter Ptac-gfp fusion (Supporting
Information Figure S1). Since LEE2 and LEE4 appear to be
expressed at higher levels than other LEE operons,38,47 we
matched the integration sites producing higher expression GFP
with eLEE2 (yeeJ) and eLEE4 (yebT), using other sites for
integration eLEE3 (yraA), eEscD (yfc) and eLEE1 (yfaL)
(Figure 1C). Transcriptional terminators of Ptac-eLEE
constructs are provided by the 3′-regions of the selected
chromosomal sites. The Ptac promoter and a strong RBS from
T7 phage was introduced upstream of the eLEE coding region.
Integration of Ptac-eLEE fusions was carried out with suicide
plasmids bearing homology regions (HRs) ﬂanking the targeted
gene. Co-integrants obtained after transformation were
resolved by homologous recombination after expression of I-
SceI in vivo, a strategy that allowed a marker-less integration of
the constructs leaving no scars nor antibiotic resistance genes in
the chromosome (Supporting Information Figure S2).48,49
Fusions of Ptac with eLEE2, eLEE3, eEscD, and eLEE4 were
sequentially integrated in the corresponding sites of EcM1. The
Ptac-eLEE1 fusion was integrated in the strain carrying the
other eLEEs generating the SIEC strain. We also attempted
initially to obtain a SIEC strain expressing Ler, but fusions
between Ptac and a longer version of eLEE1 containing ler
(eLEE1*) accumulated mutations in ler (data not shown). Ler-
containing constructs were only obtained in the absence of the
Ptac promoter, suggesting that Ler expression is toxic for E. coli
K-12. A promoter-less eLEE1* was integrated in yfaL in the
strain carrying the other eLEEs (except eLEE1), generating
SIECΔp1, which was later used as a control strain (see below).
Expression of T3SS Injectisomes in SIEC Strain. To
demonstrate the ability of SIEC to express functional
injectisomes we analyzed by SDS-PAGE the secreted proteins
of bacteria grown for 6 h in LB at 37 °C, with and without the
inducer IPTG, and compared it with those found in EPEC
grown at 37 °C in DMEM with 5% CO2 (Figure 2). Coomassie
staining revealed the presence of protein bands corresponding
to T3SS translocators EspA, EspB, EspD in the culture media
of wt EPEC and IPTG-induced SIEC, but not in negative
control strains SIECΔp1, EPECΔescN, and the parental EcM1
(Figure 2A). As expected, a protein band corresponding to the
protease domain of EspC autotransporter (not secreted
through the T3SS) was only found in EPEC strains (Figure
2A). This result strongly suggested the assembly of injectisomes
in SIEC at levels close to those found in EPEC. Importantly,
the growth curves and viability of SIEC and the parental strain
EcM1 grown in LB with IPTG were identical (Supporting
Information Figure S3), indicating that expression of the T3SS
injectisomes in SIEC was not toxic. Western blots with anti-
EspA and anti-EspB antibodies conﬁrmed the presence of
secreted EspA and EspB in cultures of wt EPEC and IPTG-
induced SIEC, but not in SIECΔp1 (Figure 2A). Small
amounts of secreted EspA and EspB were detected in SIEC
culture without IPTG, which indicate some leakiness of the
Ptac promoter. Detection of minor amounts of cytosolic
GroEL, which is conserved in all E. coli strains, was used to
control the absence of bacterial lysis in the induced cultures.
The level of injectisome proteins in bacteria harvested from
the above cultures was analyzed by Western blot with
antibodies against EspA, EspB, EscC, EscJ, EscD, and EscN
(Figure 2B). Detection of cytosolic GroEL was used in this case
as a loading control. This experiment revealed that the levels of
EscC and EscJ (eLEE2), EscD (eEscD) and EspA and EspB
(eLEE4), were slightly higher in the induced SIEC than in
EPEC. In the case of the ATPase EscN (eLEE3) we found
identical expression levels in the induced SIEC and EPEC
strains, although a small shift in their electrophoretic mobility
suggested that EscN could have a diﬀerential post-translational
processing in these strains. Although higher levels of EscC, EscJ
and EscD were found in the induced SIEC, signiﬁcant
expression of these proteins was detected in the absence of
IPTG, indicating leakiness of Ptac-eLEE2 and Ptac-eEscD
fusions. In contrast, the levels of EscN and EspA proteins were
low in the uninduced SIEC bacteria and were strongly induced
by IPTG.
Lastly, we compared the expression of injectisomes in SIEC
and the parental EcM1 strain harboring the natural LEE cloned
in the cosmid pCVD462.26 Cultures were grown at 37 °C in LB
with IPTG (adding chloramphenicol for selection in the culture
Figure 3. Interference between the assembly of injectisomes and ﬂagella. (A) Swimming motility assay of SIEC, SIECΔp1, EcM1 and EcM1Δf liCD
bacteria on soft LB-agar plates with IPTG (left) and graph representing the mean radius (with SEM) of the colonies of each strain (relative to the
values of EcM1 strain) in three independent experiments (right). (B) Coomassie staining of proteins in culture media of the indicated E. coli strains
(EcM1, SIEC, SIECΔp1, EcM1-eLEE1, and SIECΔf lhDC) grown in LB with IPTG (+). The protein bands and molecular weight markers (in kDa)
are labeled as in Figure 2
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of EcM1/pCVD462) and proteins in culture media were
analyzed by Coomassie staining of SDS-PAGE and Western
blot with antibodies against EspA and EspB. This experiment
clearly showed high levels of EspA, EspB and EspD proteins
secreted by SIEC but not by EcM1/pCVD462 strain, in which
only a faint band of secreted EspB was detectable by Western
blot (Figure 2C). This result demonstrates that the engineering
of SIEC produces higher injectisome levels than those elicited
by the cloning of natural LEE in E. coli K-12, having the
additional beneﬁts of a controlled inducible expression, lack of
eﬀectors and absence of antibiotic resistance genes.
Injectisome Assembly Interferes with Flagella in SIEC.
Coomassie staining of proteins found in culture media also
revealed that the protein band corresponding to ﬂagellin (FliC)
of E. coli K-12 (absent in EcM1Δf liCD; Figure 2A) was
strongly reduced upon induction of SIEC, but not in the
induced SIECΔp1 or EcM1/pCVD462 strains (Figure 2A and
2C). This result suggested that expression of T3SS injectisomes
was interfering with the correct expression of ﬂagella. In this
regard, we found that SIEC has a signiﬁcant reduction on its
motility (ca. 55% of the parental EcM1 strain) on LB soft-agar
plates supplemented with IPTG (Figure 3A). This reduction in
ﬂagellar motility was not observed in SIECΔp1. As expected,
the EcM1Δf liCD mutant strain lacking ﬂagellin was not motile
in this assay. Albeit in EPEC the GlrA regulator inhibits
transcription of the ﬂagellar master operon f lhDC,42 SIEC
bacteria do not express GlrA arguing for a diﬀerent mechanism
of interference. Given the structural similarities between
components of the basal bodies of T3SS injectisomes and
ﬂagella,50 we speculated that this interference could be in the
assembly or the activity of these nanomachines.
We wanted to further investigate this phenomenon to
elucidate whether this interference could be bidirectional, that
is, whether expression of ﬂagellar basal body components could
also be aﬀecting the assembly of the injectisomes in SIEC. Since
FlhDC are the master regulators required for the expression of
all ﬂagellar operons,51 we deleted f lhDC in the genome of SIEC
generating SIECΔf lhDC strain. In the absence of FlhDC the
ﬂagellar basal body is not expressed. Analysis of secreted
proteins in culture media did not show a higher level of EspA,
EspB and EspD translocators in SIECΔf lhDC than in SIEC
strain (Figure 3B). As expected, SIECΔf lhDC did not produce
ﬂagellin (FliC). This result indicates that expression of ﬂagellar
body does not interfere with assembly of T3SS injectisomes. In
contrast, induction of Ptac-eLEE1 alone, in a strain having this
operon (EcM1-eLEE1), was suﬃcient to reduce the levels of
secreted ﬂagellin (Figure 3B) and the motility of EcM1 strain
(Supporting Information Figure S4) like the induced SIEC,
whereas induction of all other eLEEs (SIECΔp1) had no eﬀect
on ﬂagellin levels and bacterial motility. Hence, protein(s)
expressed from eLEE1 speciﬁcally interfered with the activity/
assembly of the ﬂagellar apparatus. The eLEE1 encodes EscE,
CesAB, Orf4, EscL, EscR, EscS, EscT, and EscU proteins, some
of them sharing high homology to ﬂagellar components. For
instance, EscRST are homologues of FliPQR integral IM
proteins essential for the ﬂagellar function and are believed to
assemble within the IM ring of the basal body. EscL is the
regulator of the EscN ATPase and is homologue to FliH, which
also regulates the ﬂagellar ATPase. These subunits form a
conserved IM export apparatus in these two nanomachines.50
Electron Microscopy of the Injectisomes Assembled
in SIEC. We wanted to visualize the injectisomes assembled by
SIEC and compared them with those of EPEC. EspA ﬁlaments
up to 700 nm long can be observed on the surface of EPEC
bacteria expressing functional T3SS.31 Thus, EPEC, EPEC-
ΔescN, SIEC and SIECΔf lhDC bacteria were grown under
T3SS-inducing conditions, negatively stained and visualized by
transmission electron microscopy (TEM). Filamentous organ-
elles structurally compatible with EspA ﬁlaments were observed
in EPEC, SIEC, and SIECΔf lhDC bacteria (Figure 4A), but not
in EPECΔescN (negative control). The presence of EspA-like
ﬁlaments in SIECΔf lhDC ruled out that they could be ﬂagellar
ﬁlaments. Next, we attempted to isolate injectisomes from
SIEC bacteria following a puriﬁcation procedure reported for
EPEC.52 SIEC and EPEC bacteria grown under T3SS-inducing
conditions were lysed with zwitterionic detergent LDAO and
the lysate subjected to ultracentrifugation in a CsCl density
gradient. Fractions containing injectisomes were identiﬁed by
Figure 4. Visualization of the injectisomes by electron microscopy. (A) TEM micrographs of negatively stained bacteria of the indicated strains
(EPEC, EPECΔescN, SIEC and SIECΔf lhDC), grown under conditions for injectisome expression. EspA-like ﬁlaments are labeled with red
arrowheads. The scale bar is 200 nm. (B) TEM micrographs showing representative injectisome-like particles visualized in negatively stained protein
samples after injectisome puriﬁcation from induced EPEC and SIEC bacteria, as indicated. Injectisome particles are aligned at their basal bodies to
show the diﬀerent lengths of their ﬁlaments. Scale bars represent 50 nm.
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Western blot with anti-EspA antibodies (data not shown),
negatively stained and inspected by TEM (Figure 4B). Both
EPEC and SIEC samples presented similar sheath-like
structures with a basal body at one end, compatible with the
injectisomes reported in EPEC.5 Figure 4B shows 10 aligned
injectisome particles of each preparation to compare their
overall structure. The needle and basal body structures were
connected with ﬁlaments of diﬀerent lengths, having sizes
ranging between 50 and 400 nm in both SIEC and EPEC
samples. Hence, these results demonstrate that SIEC is capable
of assembling ﬁlamentous injectisomes that share an overall
structure highly similar to those assembled by EPEC.
Injection of Proteins into Mammalian Cells Using
SIEC. Next, we aimed to determine whether SIEC was capable
of forming protein translocation pores on the plasma cell
membranes of mammalian cells and inject proteins to the
cytoplasm. As a ﬁrst approach, we measured the induction of
lysis caused in red blood cells by the EspB/D translocation pore
upon contact with their membrane. This assay has been
previously used to determine the formation of functional
injectisomes by measuring the liberation of hemoglobin derived
from the lysis of erythrocytes.33 We induced the expression of
the T3SS in liquid cultures of EPEC, EPECΔescN, SIEC and
SIECΔp1 strains, and incubated harvested bacteria with a
solution of erythrocytes in DMEM at 37 °C with 5% CO2. The
hemoglobin release from erythrocytes was determined at OD
490 nm, and the activity determined for each strain was
represented relative to that of wt EPEC. As it can be observed
(Figure 5), bacterial strains lacking a functional T3SS displayed
weak hemolytic activity, albeit the background activity (non-
T3SS dependent) of EPECΔescN was higher than that of
SIECΔp1. In contrast, SIEC retained ca. 70% of the hemolysis
of EPEC, a value that could be underestimated given the lower
background activity of SIECΔp1. Therefore, these data indicate
that EspB/D translocators of SIEC can assemble pores on the
plasma membrane of the mammalian cells.
We investigated the ability of SIEC injectisomes to recognize
a speciﬁc protein substrate and translocate it in a biologically
active form into human cells (e.g., HeLa). We selected Tir as a
model protein to test the translocation capacity of SIEC
injectisomes since, when injected through the T3SS, it triggers
bacterial intimate attachment to the mammalian cell and
formation of actin-rich pedestals, a phenotype that can be easily
visualized by ﬂuorescence microscopy.24 In EPEC this
phenotype requires expression of intimin on the bacterial
surface, which interacts with a domain of Tir exposed on the
host plasma membrane. Intimin-Tir interaction induces
polymerization of F-actin underneath the bound bacterium
mediated by the clustering of phosphorylated cytoplasmic
domains of Tir that recruit Nck and other cellular proteins.25 A
simpliﬁed model of this process is shown in Supporting
Information Figure S5. In EPEC, the operon LEE5 encodes Tir,
its chaperone CesT, and intimin (Figure 1A). Following the
strategy used for eLEEs, we generated an eLEE5 operon under
the control of Ptac (Figure 6A) that was integrated in the
chromosome of SIEC, replacing the adhesin f lu gene (Antigen
43),53 obtaining the strain SIEC-eLEE5. The Ptac-eLEE5 was
also integrated in the same site of the chromosome of
SIECΔp1, obtaining strain SIECΔp1-eLEE5, which is defective
in the assembly of injectisomes.
The expression of intimin and Tir in IPTG-induced SIEC-
eLEE5 and SIECΔp1-eLEE5 bacteria was evaluated by Western
blot of whole-cell protein extracts and compared with their
expression in EPEC and EPECΔescN strains (Figure 6B). Tir
was detected in all of the strains, though EPEC and SIEC-
eLEE5 appeared to express slightly higher levels than T3SS-
defective strains. Intimin was also well expressed in all of the
strains, albeit its expression levels were reduced ∼3-fold in
SIEC strains compared to EPEC. Analysis of proteins found in
culture media (Figure 6B) showed that translocators EspA,
EspB and EspD were secreted by SIEC-eLEE5 normally,
indicating that induction of the eLEE5 proteins does not aﬀect
the assembly of SIEC injectisomes.
Subsequently, we analyzed whether SIEC-eLEE5 was able to
translocate Tir into HeLa cells. To visualize SIEC bacteria in
ﬂuorescence microscopy, we transformed SIEC-eLEE5 and
SIECΔp1-eLEE5 with the stable plasmid pGEN22, which
expresses GFP constitutively.54 GFP-labeled SIEC-eLEE5 and
SIECΔp1-eLEE5 bacteria were grown in LB with IPTG to mid
log phase and then incubated with HeLa cells for 3 h with
IPTG (MOI = 100). Infections of HeLa cells with EPEC and
EPECΔescN bacteria were conducted in parallel as positive and
negative controls, respectively, albeit for 90 min to reduce the
cytotoxic eﬀects of EPEC. After infection, samples were
washed, ﬁxed, and stained for ﬂuorescence microscopy to
visualize bacteria, F-actin, and DNA. This experiment showed
SIEC-eLEE5 bacteria adhered to the surface of HeLa cells with
intense F-actin accumulation beneath the bound bacteria,
highly similar to the actin-pedestals triggered by EPEC (Figure
6C). On the contrary, SIECΔp1-eLEE5 bacteria were unable to
attach to HeLa cells, being washed out of the preparation and
not inducing any alteration in the actin cytoskeleton. SIECΔp1-
eLEE5 has less adhesive properties than EPECΔescN bacteria,
albeit both strains do not trigger actin-pedestal formation.
EPEC bacteria express diﬀerent adhesins independent of the
Figure 5. Hemolytic activity of bacteria expressing injectisomes. The
ability of injectisome-expressing bacteria to form pores in the plasma
membrane of mammalian cells was evaluated by the release of
hemoglobin from red blood cells measured at OD 450 nm after
incubation with the indicated strains (EPEC, EPECΔescN, SIEC,
SIECΔp1). The mean data and the standard error (SEM) of three
independent experiments are represented. The hemolytic activity
obtained by wt EPEC was considered 100%. In all cases, background
hemolytic activity obtained with EcM1 bacteria was subtracted from
the represented values. The statistical analysis was performed using
Student’s t test comparing the indicated groups (*** indicates p-values
<0.001).
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.5b00080
ACS Synth. Biol. 2015, 4, 1030−1041
1035
ﬁlamentous T3SS (e.g., the bundle forming pili, BFP, and E. coli
common pili, ECP)55 that are not expressed by SIEC. Hence,
this experiment demonstrates that SIEC-eLEE5, similar to
EPEC, is able to inject functional Tir into HeLa cells, which
inserts in the plasma membrane and interacts with intimin on
the bacterial surface to mediate intimate attachment and the
formation of actin pedestals beneath the adhered extracellular
bacterium.
Concluding Remarks. The controlled expression of
complex protein nanomachines in microorganisms designed
for biomedical or environmental applications represents an
important challenge for synthetic biology. T3SS are attractive
protein delivery systems for the injection of proteins into
mammalian cells whose potential have been assessed using
diﬀerent attenuated strains of pathogens, including EPEC,
Pseudomonas aeruginosa, and Salmonella strains.10−15 Despite
their interest, it is diﬃcult to transfer these protein delivery
devices to nonpathogenic bacteria due to their structural and
regulatory complexity. In this work we have engineered the
controlled assembly of functional injectisomes from the
ﬁlamentous T3SS of EPEC in the nonpathogenic strain E.
coli K-12 demonstrating the injection of proteins recognized by
this system into mammalian cells in a biologically active form.
We followed a synthetic biology approach to tackle the
expression of T3SS injectisomes of EPEC in a bacterium of
choice. We generated ﬁve engineered TUs (eLEE1, eLEE2,
eLEE3, eLEE4, eEscD) that encode all the structural subunits,
chaperones, energizing ATPase, and translocators known to be
required for assembly of these injectisomes, but not the
transcriptional regulators, native promoters and eﬀectors also
encoded within the LEE. Control expression of these eLEEs
was achieved with heterologous inducible Ptac promoters,
including signals for translation initiation and transcriptional
termination. These genetic fusions were integrated by
homologous recombination at distinct sites of E. coli K-12
chromosome encoding nonessential adhesins.44−46 By modify-
ing the ﬂanking HRs of the suicide vectors, the designed eLEEs
could be inserted at diﬀerent loci and other bacteria. Likewise,
the modular architecture of eLEEs allows the exchange the Ptac
for alternative promoters appropriated for speciﬁc applications
(e.g., PBAD and Ptet promoters for in vivo induction).
56
Integration of the eLEEs under Ptac control generated the
SIEC strain, which upon IPTG-induction was shown to
assemble ﬁlamentous injectisomes similar to those found in
EPEC bacteria.5 The long EspA-ﬁlaments of these injectisomes
are known to have adhesin properties,57 thus assisting the
binding of extracellular bacteria to mammalian cells and
allowing translocation of proteins “at-a-distance” from the
plasma membrane of the host, even when shielded by
extracellular mucins.5,30,58 In addition, the adhesion of SIEC
to speciﬁc target cells could be implemented based on the
expression on the bacterial surface of synthetic adhesins that
can bind to antigens expressed on the surface of mammalian
cells.49 Importantly, we found that expression of EPEC
injectisomes does not aﬀect the growth of SIEC bacteria.
Nonetheless, expression of eLEE1 (alone or in combination
with other eLEEs) reduces the assembly of ﬂagella and the
motility of SIEC bacteria, likely due to the similarities between
components of eLEE1 and the ﬂagellar basal body.50 Hence, in
those instances in which bacterial motility may be required for
Figure 6. Translocation of Tir protein into HeLa cells by the injectisomes of SIEC. (A) Scheme of the engineered operon (eLEE5) encoding Tir, its
chaperone CesT, and intimin (eae), under Ptac regulation and integrated at the f lu locus of SIEC-eLEE5 and SIECΔp1-eLEE5 strains. (B) Proteins
in the culture media of the indicated strains (EPEC, EPECΔescN, SIEC-eLEE5, SIECΔp1-eLEE5) grown under conditions for injectisome
expression and analyzed by SDS-PAGE and Coomassie staining (top panel). The expression of intimin (Int) and Tir was detected in the bacterial
whole-cell extract by Western blot with speciﬁc antibodies (bottom panels). GroEL was used as a loading control. Protein bands and molecular
weight markers indicated as in Figure 2. (C) Confocal ﬂuorescence microscopy images of HeLa cells infected with the indicated bacterial strains
(EPEC, EPECΔescN, SIEC-eLEE5, SIECΔp1-eLEE5) and stained with TRITC-conjugated phalloidin (red) to visualize F-actin and DAPI (gray) to
visualize DNA and nuclei. EPEC bacteria are labeled with anti-intimin280 and ALEXA488-conjugated antirabbit antibodies (cyan). Fluorescence
signals of SIEC bacteria expressing GFP are also colored in cyan. Strong red ﬂuorescence signals are clearly visible beneath adhered EPEC and SIEC-
eLEE5 bacteria indicating F-actin pedestal formation triggered by translocated Tir protein.
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.5b00080
ACS Synth. Biol. 2015, 4, 1030−1041
1036
eﬃcient colonization of tissues,59 induction of the injectisomes
should be triggered at a later stage.
Lastly, we demonstrated the ability of SIEC to form pores on
the membrane of erythrocytes and to inject a protein
recognized by this T3SS into HeLa cells.60 We selected the
natural eﬀector Tir as a model to test functionality of SIEC
injectisome because of the evident phenotypic eﬀect caused by
its translocation, the formation of actin-rich pedestals beneath
attached bacteria.25 Tir could be easily replaced by other
protein(s) of interest, either natural T3SS eﬀectors inducing a
speciﬁc biological activity in the cell (e.g., apoptosis, anti-
inﬂammation responses),21,22 or heterologous proteins such as
single-domain antibody fragments,13,61 enzymes (e.g., β-
lactamase),62 transcription activator-like eﬀector nucleases
(TALENs),10 or eukaryotic transcription factors (e.g.,
MyoD),63 all of which have been translocated with T3SS of
attenuated pathogens. In order to be recognized by SIEC
injectisomes, these heterologous polypeptides need to be fused
to signals located in the N-terminus of natural eﬀectors (e.g.,
ﬁrst 20 amino acids of EspF)62 and translocators.64 The use of
longer N-terminal signals (ca. 100 amino acids) including the
binding domains of eﬀector chaperones (e.g., CesF, CesT) may
increase translocation eﬃciency65−67 but they could incorpo-
rate some eﬀector functions and subcellular localization signals
(e.g., mitochondrial targeting signals).68 These longer T3 signals
may interfere with the activity of the heterologous polypeptide
within the cell and should be tested on a one-to-one basis. In
summary, the SIEC strain developed in this work can be
considered a nonpathogenic bacterial chassis that can be further
modiﬁed to direct the injection of diverse proteins into
mammalian cells using the ﬁlamentous injectisomes of EPEC.
■ METHODS
Bacterial Strains and Growth Conditions. E. coli strains
used in this work are listed in Supporting Information Table S2.
Bacteria were grown at 37 °C in Lysogeny broth (LB) agar
plates (1.5% w/v),69 in liquid LB medium or in Dulbecco’s
Modiﬁed Eagle Medium (DMEM), unless otherwise indicated.
When needed, antibiotics were added at the following
concentrations for plasmid or strain selection: chloramphenicol
(Cm) at 30 μg/mL; kanamycin (Km) at 50 μg/mL;
tetracycline (Tc) at 10 μg/mL; spectinomycin (Sp) at 50 μg/
mL; ampicillin (Ap) at 150 μg/mL, except for strains
expressing the Ap resistance gene from their chromosome,
which were selected at 75 μg/mL. EPEC strains were grown
overnight (o/n) with agitation (200 rpm) at 37 °C in a ﬂask
with 10 mL of liquid LB. Next day, cultures were inoculated in
capped Falcon tubes (BD Biosciences) with 5 mL DMEM and
incubated in static conditions for 2.5 h for the expression of the
T3SS. These cultures were used at this point to infect cell
cultures. Alternatively, for the analysis of the T3-secreted
proteins, the cultures were grown for additional 3.5 h in
DMEM. For the analysis of T3-secreted proteins by SIEC
strains, bacteria were grown in capped Falcon tubes with 5 mL
of liquid LB and 0.1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) with agitation (160 rpm) for 6 h. For the infection of
cell cultures with SIEC strains, bacteria were grown as above for
2.5 h and then added to mammalian cell cultures in DMEM
with 0.1 mM IPTG for 3 h.
Plasmids, DNA Constructs, and Primers. Plasmids used
in this study are listed in Supporting Information Table S3. E.
coli DH10B-T1R strain was used as host for the cloning and
propagation of plasmids with pBR/pUC- and pSC101-ts origins
of replication. In the case of suicide pGE-plasmid derivatives
harboring the conditional pi-dependent R6K origin of
replicationE. coli strains BW25141 or CC118-λpir were
used (Supporting Information Table S2). The proofreading
DNA polymerase Herculase II Fusion (Agilent Technologies)
was used to amplify DNA fragments for cloning purposes.70
PCR products longer than 3 kb were inserted in the pCR-
BluntII-TOPO plasmid (Zero Blunt TOPO PCR Cloning Kit,
Life Technologies) prior to the cloning in the ﬁnal vector. All
plasmid constructs were fully sequenced (Secugen SL, Madrid,
Spain). Details of plasmid constructions and oligonucleotide
primers are described in the Supporting Information and Table
S4.
E. coli Genome Modiﬁcation and Strain Construction.
Site-speciﬁc deletions and insertions in the chromosome of E.
coli were originated using a marker-less genome edition strategy
based on the generation of double-strand breaks in vivo with I-
SceI endonuclease.48,71 Construction details of individual E. coli
strains are described in the Supporting Information (Table S5).
The E. coli strains to be modiﬁed were initially transformed
with a SpR-derivative of plasmid pACBSR72 (expressing the I-
SceI and λ Red proteins under the control of the PBAD promoter
(inducible with L-arabinose). Subsequently, these bacteria were
electroporated with the corresponding pGE-based suicide
vector (KmR) carrying the indicated HRs, gene construct, and
I-SceI restriction sites.49 Individual KmR-colonies of the initial
integration of the plasmid were grown for 6 h in LB-Sp liquid
medium containing L-arabinose 0.4% (w/v) with agitation (200
rpm) to induce the expression of I-SceI and the cleavage of the
chromosome at the integration site, promoting a second step of
homologous recombination that elicits deletion of vector
sequences and integration of gene constructs (Supporting
Information Figure S2). A sample of these cultures was streaked
on LB agar plates and incubated o/n to isolate individual
colonies, which were replicated in LB and LB-Km agar plates to
identify Km-sensitive colonies. Using speciﬁc primers, the
modiﬁed strains were identiﬁed by PCR screening. Plasmid
pACBSR-Sp was cured from the ﬁnal strains.
Those E. coli strains to be modiﬁed using the pGETS
plasmids were transformed with plasmid pACBSR-Sp as above,
and the corresponding pGETS plasmid (KmR) - which contains
the thermosensitive origin of replication pSC101-ts. The ApR-
marker ﬂanked by Flippase Recognition Target (FRT) sites was
incorporated in these vectors downstream of eLEEs. Individual
colonies were grown at 30 °C in liquid LB medium with
agitation (200 rpm) and at OD600 0.5, L-arabinose 0.4% (w/v)
was added and the temperature was shifted to 37 °C to avoid
plasmid replication. The cultures were further grown during 4 h
and streaked in LB-Km-Sp plates to select the initial
cointegrants. Individual cointegrant colonies were resolved by
I-SceI expression and bacteria with insertion of the gene
construct were selected in LB-Ap plates and tested for
sensitivity to Km by replica-plating as above. Lastly, the ApR
gene was excised by the recombination of the FRT sites with
Flippase expressed from plasmid pCP20 (CmR).73 Individual
Ap-sensitive colonies were selected and integration of the gene
construct conﬁrmed by PCR and DNA sequencing (Secugen
SL, Madrid, Spain).
SDS-PAGE and Western Blot. Sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blot were performed following standard methods74 using the
Miniprotean III system (Bio-Rad). Proteins separated by SDS-
PAGE were either stained with Coomassie Blue R-250 (Bio-
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Rad) or transferred to a polyvinylidene diﬂuoride membrane
(PVDF, Immobilon-P, Millipore) for Western blot using
semidry transfer (Bio-Rad). Electrophoresis and transfer
conditions, including buﬀers for blocking, washing and
incubation of PVDF-membranes, were reported previously.75
These membranes were incubated with primary rabbit
antibodies anti-EscC (1:1000), anti-EscD (1:1000), anti-EscN
(1:500), anti-EscJ (1:5000), anti-EspA (1:2000), anti-EspB
(1:5000), anti-Tir (1:5000) and anti-intimin280 (1:5000) to
detect T3SS components. Polyclonal sera against EscC, EscN
and EscD were obtained by immunization of New Zealand
White rabbits (Granja San Bernardo, Navarra, Spain) as
described in the Supporting Information. Rabbit polyclonal
sera against EspA, Tir and intimin-280 were a kind gift of Prof.
Gad Frankel (Imperial College London). Rabbit polyclonal
serum against EspJ was a kind gift of Prof. Bertha Gonzaĺez-
Pedrajo (UNAM, Mex́ico). In all cases, bound rabbit antibodies
were detected with secondary Protein A-peroxidase (POD)
conjugate (Life Technologies, 1:5000). GroEL was detected
with anti-GroEL-POD conjugate (1:5000; Sigma). Membranes
were developed by chemiluminiscence using the Clarity
Western ECL Substrate kit (Bio-Rad) and exposed to X-ray
ﬁlms (Agfa) and to a ChemiDoc XRS system (Bio-Rad) for
quantiﬁcation of light emission in the protein bands (Quantity
One Software, Bio-Rad).
To analyze the secretion of T3SS components in SIEC and
EPEC strains, cells were harvested from 1 mL aliquots of the
induced cultures by centrifugation (5000g, 5 min, RT). To
obtain whole-cell protein extracts, bacteria were resuspended in
400 μL of phosphate-buﬀered saline (PBS), mixed with 100 μL
of 5X SDS-PAGE sample buﬀer76 and boiled for 10 min.
Culture supernatants obtained after centrifugation were chilled
on ice and incubated 60 min with trichloroacetic acid (TCA
20% w/v; Merck) for precipitation. After centrifugation
(20000g, 15 min, 4 °C), TCA-precipitated protein pellets
were rinsed with cold acetone (−20 °C), air-dried and
resuspended in 30 μL of SDS-PAGE sample buﬀer for
Coomassie staining or Western blot.
T3SS-Mediated Erythrocyte Hemolysis. The protocol
was performed as previously described.33 Brieﬂy, erythrocytes
were obtained from a 5 mL blood sample obtained from New
Zealand White rabbits (Granja San Bernardo, Navarra, Spain).
The blood was treated adding 500 μL of EDTA 1% (w/v) pH
7.5 (100 μL for each ml) to avoid coagulation and was
centrifuged (3500g, 15 min, RT) to concentrate the
erythrocytes. The solution was washed 3 times with one
volume of NaCl 0.9% (w/v) followed by centrifugation (1000g,
10 min, RT). The assembly of the T3SS was induced in the
indicated cultures as described above until they reached OD600
0.4. Then, 0.5 mL of the cultures and 0.5 mL of the
erythrocytes suspension (previously diluted to a 4% in
DMEM) were mixed in 1.5 mL tubes. The ﬁnal mixture was
centrifuged (2500g, 1 min, RT) to induce the contact of the
bacteria with the erythrocytes, incubated at 37 °C with 5% CO2
during 4 h, and then the erythrocyte pellets were softly
resuspended. The samples were centrifuged (12000g, 1 min,
RT) and the hemoglobin release to the supernatant was
measured at OD450 in a spectrophotometer (Ultraspec 3100
pro, Amersham Biosciences). The hemolysis induced by the wt
EPEC strain was considered 100%. Background hemolysis
induced by E. coli K-12 strain EcM1 was subtracted from the
values obtained in all samples. The experiment was repeated
three times, each one with triplicates.
Infection of Cell Cultures and Fluorescence Confocal
Microscopy. The human cell line HeLa (CCL-2, ATCC) was
grown as monolayer in DMEM, supplemented with 10% fetal
bovine serum (FBS; Sigma) and 2 mM L-glutamine, at 37 °C
with 5% CO2. Induced EPEC was used for infection of HeLa
cell cultures (105 cells/well in 24-well tissue culture plates;
Falcon) at a multiplicity of infection (MOI) of 100:1 and
infection continued at 37 °C with 5% CO2 for 90 min. SIEC
strains (carrying pGEN22 for GFP expression) were induced
for 2.5 h with 0.1 mM IPTG (as described above) and used to
infect HeLa cells at a MOI of 100:1 for 3 h. Infections were
stopped by three washes of sterile PBS, and ﬁxed with 4% (w/
v) paraformaldehyde (in PBS, 20 min, RT). Samples were then
washed with PBS three times and permeabilized by incubation
with 0.1% (v/v) saponin (Sigma) in PBS for 10 min. To stain
EPEC strains, bacteria were incubated with polyclonal rabbit
Ab anti-intimin280 (1:500) in PBS with 10% (v/v) goat serum
(Sigma) and incubated for 60 min at RT. Coverslips were
washed three times with PBS and were then incubated for 45
min with goat antirabbit secondary antibodies conjugated to
ALEXA488 (1:500; Life Technologies) in PBS with 10% goat
serum, along with Phalloidin-Tetramethylrhodamine (TRITC)
(1:500; Sigma) and 4′,6-diamidino-2-phenylindole (DAPI)
(1:500; Sigma) to label F-actin and DNA, respectively.
Coverslips were washed 3 times with PBS after incubation
and 4 μL of ProLong Gold antifade reagent (Life
Technologies) was added. They were then observed at the
SP5 confocal microscope (Leica) using the 100× objective and
an additional 2.5-fold magniﬁcation. The images were
processed using the ImageJ software.77
Injectisome Puriﬁcation. The protocol was adapted from
a previously reported method.52 Cultures of EPEC and SIEC
derived strains were grown in 20 mL of LB o/n with agitation
(200 rpm). Next day, these cultures were used to inoculate 950
mL of prewarmed DMEM in the case of EPEC or LB in the
case of SIEC. Bacteria were grown with gentle agitation (100
rpm) until reaching OD600 of 0.8 and then centrifuged to
harvest bacteria (6000g, 15 min). The supernatant was
discarded and the pellet was resuspended in 80 mL of sucrose
solution (150 mM Tris-HCl pH 8.0, 0.5 M sucrose). The
suspension was agitated for homogenization at 4 °C and 8 mL
of freshly prepared lysozyme solution (10 mg/mL) were added
drop by drop. Then, EDTA was added at a ﬁnal concentration
of 2 mM and incubated for 60 min. Bacteria were then lysed
with 0.3% (w/v) de lauryldimethylamine oxide (LDAO;
Sigma). The lysate was supplemented with 12 mM of MgSO4
and 450 mM of NaCl (ﬁnal concentrations) and centrifuged
(25000 g, 20 min, 4 °C). The supernatant of previous
centrifugation was collected and then ultracentrifuged (3 h,
70000g, 4 °C) and the viscous pellet was resuspended in 2 mL
of buﬀer F (10 mM Tris-HCl pH 8.0, 0.1% LDAO, 0.3 M
NaCl, 5 mM EDTA). This solution was loaded onto a 30% (w/
v) CsCl “cushion” reaching a ﬁnal volume of 12 mL, which was
ultracentrifuged (50000g, 16 h, 20 °C). Fractions of 0.5 mL
from the CsCl gradient were collected, diluted with 3.5 mL of
buﬀer F and ultracentrifuged (130000g, 30 min, 4 °C). The
protein pellets were resuspended in 100 μL of buﬀer F and kept
on ice for Western blot analysis with anti-EspA antibodies.
Injectisomes were visualized by transmission electron micros-
copy (TEM) in the protein fractions having higher levels of
EspA.
Electron Microscopy. A sample (5 μL) of the puriﬁed
protein fractions with high level of EspA (see above) was
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applied to collodion-coated copper grids and incubated for 2
min at RT. After that, grids were washed 3 times with deionized
water (Milli-Q, Millipore). Next, samples were incubated with
uranyl acetate in a 2% (w/v) solution in deionized water for 1
min. Excess of uranyl acetate solution was removed and the
grids were further washed with deionized water. Images were
taken with a JEOL 1200EX-II electron microscope operated at
100 kV and recorded at a nominal magniﬁcation of 100000×.
For the visualization of injectisomes on the bacterial surface,
cultures of induced of EPEC or SIEC strains (1 mL) were
centrifuged softly (100g, 10 s, RT) in 1.5 mL tubes to
concentrate bacteria. Then, 5 μL taken form the bottom of the
tube, were applied to collodion-coated copper grids and
incubated for 2 min at RT. The negative staining was
performed as above, but using a 1% (w/v) solution of uranyl
acetate and a magniﬁcation of 50000× at the electron
microscope.
Statistics. Mean and standard errors of experimental values
calculated with using Prism 5.0 (GraphPad software Inc.).
Statistical analyses comparing the mean of paired experimental
groups were conducted with Student’s t test using Prism 5.0
(GraphPad software Inc.). Data were considered signiﬁcantly
diﬀerent when p-values <0.05.
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